# Safety Study of Tecadenoson to Treat Atrial Fibrillation

> **NCT00713401** · PHASE2 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 21 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Tecadenoson
- **DRUG:** Esmolol

## Key facts

- **NCT ID:** NCT00713401
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-04
- **Final completion:** 2008-07
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2014-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00713401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00713401, "Safety Study of Tecadenoson to Treat Atrial Fibrillation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00713401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*